A Major Scientific Breakthrough From Novel Gymnema Sylvestre Isolate Research May Provide A New Therapy For Type 2 Diabetes

Main Category: Diabetes
Article Date: 13 Apr 2009 - 0:00 PDT

email icon email to a friend   printer icon printer friendly   write icon opinions  

Current Article Ratings:

Patient / Public:4 and a half stars

4.38 (8 votes)

Healthcare Prof:not yet rated


Ayurvedic-Life International, LLC announced today that it's sponsored research at King's College-London featuring it's multi-patented next-generation Gymnema sylvestre extract, "validates its development for clinical use" per a research paper published in Cellular Physiology and Biochemistry, February 2009;23:125-132.

Low concentrations of the novel Gymnema sylvestre isolate stimulate insulin secretion in-vitro without compromising pancreatic beta cell viability, unlike the commonly used GS-4 standardized Gymnema sylvestre extract. Ayurvedic-Life's novel Gymnema sylvestre isolate has the ability to stimulate insulin secretion similar to sulphonylureas and meglitinide analogues that are currently used for the treatment of Type 2 Diabetes.

Ayurvedic-Life's novel Gymnema sylvestre isolate is produced from their patented proprietary extraction process that preserves the labile compounds of the key Active Principles of botanically pure Gymnema sylvestre leaves. Gymnema sylvestre is a unique plant that grows primarily in the Indian sub-continent and has been used as a natural folk medicine for maintaining optimal health since 6,000 B.C. Several tribes, including the Santals in east-central India have used Gymnema sylvestre leaves for centuries as a folk remedy.

Dr. Arun K. Chatterji, PhD, the inventor of the patented Gymnema sylvestre Virgin Isolate extraction technology and the Chairman and CEO of Ayurvedic-Life International, states, "My invention of the Ayurvedic Virgin Isolate technology coupled with the superb cellular level research performed at King's College-London has the potential to bring a truly unique health solution to millions of people worldwide."

For more information on the research conducted at King's College-London and their complete research paper, please visit http://www.karger.com/cbp.

About Ayurvedic-Life International, LLC

Located in Neenah, WI, Ayurvedic-Life International, LLC, is focused on developing novel proprietary compounds form natural substances to improve the health of mankind. For more information, please call 920-968-0988 or visit http://www.ayurvedic-life.com.

Source
Ayurvedic-Life International, LLC

Article adapted by Medical News Today from original press release.
Visit our diabetes section for the latest news on this subject.
There are no references listed for this article.
Please use one of the following formats to cite this article in your essay, paper or report:

MLA
Ayurvedic-Life International, LLC. "A Major Scientific Breakthrough From Novel Gymnema Sylvestre Isolate Research May Provide A New Therapy For Type 2 Diabetes." Medical News Today. MediLexicon, Intl., 13 Apr. 2009. Web.
12 Feb. 2012. <http://www.medicalnewstoday.com/releases/145449.php>

APA
Ayurvedic-Life International, LLC. (2009, April 13). "A Major Scientific Breakthrough From Novel Gymnema Sylvestre Isolate Research May Provide A New Therapy For Type 2 Diabetes." Medical News Today. Retrieved from
http://www.medicalnewstoday.com/releases/145449.php.

Please note: If no author information is provided, the source is cited instead.


Diabetes

What is Diabetes?

Diabetes (diabetes mellitus) is classed as a metabolism disorder. Metabolism refers to the way our bodies use digested food for energy and growth. Most of what we eat is broken down into glucose. Glucose is a form of sugar in the blood... Read more...

Most Popular Articles



Follow Our Diabetes News On Twitter

Follow Us On Twitter
Get the latest news for this category delivered straight to your Twitter account. Simply visit our Diabetes Twitter account and select the 'follow' option.



View list of all 'What Is...' articles »